Pricing
Sign up
W15

20n

Go to market map
Similar Companies
+3 more
Sign in for full access
Short description
A computational synthetic biology company.
Description
At 20n, They use algorithms to engineer microbes. Specifically, their algorithms engineer microbes to make chemicals. Like yeast produces alcohol during beer brewing, their engineered microbes will produce chemicals with therapeutic health and industrial biotech applications. The best illustration of this DARPA-backed technology is the bacteria They engineered to produce Paracetamol (also known as acetaminophen, and sold under the brand name Tylenol). Aside from this bacteria, there is no known natural way of producing acetaminophen. They are building data mining technology that will allow us to enable the bioproduction of a whole spectrum of valuable molecules. Below is the map of every chemical that can be made biologically, as discovered by 20n's algorithms.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
San Francisco, California, United States, North America
Founded on
January 1, 2013
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
Uh Ohhhh, Noway Youcantaccess, Cannot Access, Noaccessforu, Noaccess, Nopepepe
Sign in for full access
Founders
J.Christopher Anderson, Saurabh Srivastava